Biotechnology News
Cutting edge news about companies engaged in the research and development of new drugs, medical devices and procedures as well as research, books and information on FDA approvals, patents and awards. Biotechnology news highlights the use of biological processes, organisms or systems to manufacture products that improve the quality of life.
AnaSpec Introduces Two New IRAK1 Antibodies – pThr 209 & 387
AnaSpec has introduced two new phosphospecific IRAK1 polyclonal antibodies – anti-IRAK1 (pThr 209) and anti-IRAK1 (pThr387). - December 18, 2008 - AnaSpec, EGT Group
AnaSpec Introduces Industry’s First Fluorimetric Assay Kit for Aggrecanase-1 Activity Detection
AnaSpec has announced the release of the industry’s first fluorimetric assay optimized to detect ADAMTS-4 (aggrecanase-1) activity - the SensoLyteTM 520 Aggrecanase-1 Assay Kit. A FRET based assay, it is homogeneous and has an emission in the green range (Ex/Em= 490 nm/520 nm). The kit... - December 17, 2008 - AnaSpec, EGT Group
Is Algae Oil Fuel or Nutrition?
New algae oil products are valuable as Omega-3 DHA Therapy™ [patent pending] for high triglycerides and serving diabetes. A recent international peer reviewed publication places a question mark on biodiesel from algae oil as a current business model for commercialization. The future remains to be seen. Now, in contrast, the report points to commercial viability instead in omega-3 nutritional oils. - December 10, 2008 - Source-Omega
GeneThera Will Test Raw and Processed Milk for Johne’s Disease Due to Evidence Linking Johne’s Disease to Irritable Bowel Syndrome (IBS) and Chron’s Disease
GeneThera will test raw and processed milk for Johne’s disease due to evidence linking Johne’s disease to Irritable Bowel Syndrome (IBS) and Chron’s disease starting January, 2009. GeneThera, Inc. (GTHR.PK), GeneThera announces it will soon begin testing of raw and processed milk... - December 10, 2008 - GeneThera Inc.
Functional Genetics, Inc. Announces Agreement with Elanco, a Division of Eli Lilly and Company
Functional Genetics, Inc., a biotechnology research and development company, announced today that it has reached a collaborative research, license and commercialization agreement with Elanco, the animal health division of Eli Lilly and Company. The agreement establishes the framework for... - December 09, 2008 - Functional Genetics, Inc.
AnaSpec Signs Distribution Agreement with Yope Biotechnology
AnaSpec and Yope Biotechnology Co. Ltd. today announced a non-exclusive distributor agreement that will allow Yope Biotechnology Co. Ltd. to distribute AnaSpec’s catalog and custom products throughout China. AnaSpec’s Director of Sales & Marketing, Violeta Rajkovska, noted,... - December 04, 2008 - AnaSpec, EGT Group
AnaSpec Signs Distribution Agreement with Biogenuix Medsystems
AnaSpec and Biogenuix Medsystems Pvt. Ltd. today announced a non-exclusive distributor agreement that will allow Biogenuix Medsystems Pvt. Ltd. to distribute AnaSpec’s catalog and custom products throughout India. AnaSpec’s Director of Sales & Marketing, Violeta Rajkovska, noted,... - November 28, 2008 - AnaSpec, EGT Group
AnaSpec Introduces New Line of LL-37 GO™ Peptides
LL-37 peptides are AnaSpec’s latest addition to their expansive collection of research-ready, on-demand GO™ Peptides. - November 27, 2008 - AnaSpec, EGT Group
Accugenix Announces New CEO & President, Retains Former as R&D VP; Former COO Roger Nalepa Takes the Reins and Former CEO Doug Smith Refocuses on R&D
Accugenix, Inc. publicly announced today the promotion of former COO, Roger Nalepa, to the position of CEO & President, and the reassignment of former CEO Doug Smith to Vice President of Research & Development. Specializing in genetic microbial identification, the Delaware-based DNA... - November 27, 2008 - Accugenix, Inc.
Biotech Executive John Collar Named Executive Director of the Colorado BioScience Association, Effective December 8
Following an extensive national search, John Collar, Chief Operating Officer of Westminster-based Matrilinex, has been named Executive Director of the Colorado BioScience Association (CBSA), effective December 8, 2008. A seasoned senior executive, Collar has a background of solid corporate experience with a proven track record for strategic planning, managing to metrics, and c-level operational responsibilities. He succeeds Denise Brown, Founding Executive Director of CBSA, who retired Sept 30. - November 24, 2008 - Colorado BioScience Association
AnaSpec Releases 4 New Phosphospecific Anti-Tau Antibodies
AnaSpec is excited to announce the release of 4 more new phosphospecific anti-Tau antibodies. This represents the industry’s largest collection of anti-Tau antibodies - 17 phosphospecific and 9 non-phosphospecific antibodies. AnaSpec’s expertise in phosphopeptide synthesis combined... - November 23, 2008 - AnaSpec, EGT Group
Innovatech Labs, Leading Materials Testing Laboratory, Helps Companies Adhere to Halogen-Free Manufacturing Standards Aimed at Protecting the Environment
Ion Chromatography tests deployed on electronic components to determine levels of halogens. - November 22, 2008 - Innovatech Labs
AnaSpec Signs Distribution Agreement with Shanghai Universal Biotech Company
AnaSpec and Shanghai Universal Biotech Company today announced a non-exclusive distributor agreement that will allow Shanghai Universal Biotech Company to distribute AnaSpec’s catalog and custom products throughout China. - November 22, 2008 - AnaSpec, EGT Group
Oberon FMR, Inc., Wins the Fourth Annual Dorsey & Whitney Venture Showcase Award, Presented at BioWest 2008
Oberon FMR, Inc., has won the fourth annual Dorsey & Whitney Venture Showcase Award at the 2008 BioWest Conference & Expo in Denver. The announcement is made by Christine Shapard, Interim Executive Director of the Colorado BioScience Association (CBSA), who says the $10,000 Venture Showcase award was provided by the Dorsey & Whitney law firm and announced at the Colorado Bioscience Association (CBSA) 2008 Awards Dinner. - November 19, 2008 - Colorado BioScience Association
New Regional Biotech Association Formed
600+ Member Organization Will Focus on Policy/ Public Affairs in New England. A non-profit, member-driven organization comprised of state biotech associations, companies, academic institutions, and other organizations with a collective mission to support and grow the biotechnology industry in New... - November 19, 2008 - Tech Collective
AnaSpec Establishes New Dedicated GMP Manufacturing Facility
In response to increased demand for GMP peptide production, AnaSpec has established a new facility dedicated to GMP manufacturing. Located adjacent to its current San Jose, California-based headquarters, the expansion provides an additional 5000 sq. ft. of dedicated GMP space including two class... - November 16, 2008 - AnaSpec, EGT Group
Low Wages & Govt Support Pushing China Ahead of Other Asia-Pacific Biotech Markets: RNCOS
China’s biotech market has an edge over other Asia-Pacific countries in terms of labor cost and government support that makes it one of the most potential biotech destinations in the world. - November 15, 2008 - RNCOS
AnaSpec Introduces Series of Luminescent and Non-Luminescent Calcium Indicators
AnaSpec offers coelenterazine and several synthetic coelenterazine analogs for reconstituting aequorin in cells that have been transfected with apoaequorin cDNA. - November 14, 2008 - AnaSpec, EGT Group
AnaSpec Introduces Improved AnaTagTM APC, B-PE and R-PE Labeling Kits
AnaSpec is pleased to announce the release of the improved AnaTagTM APC, B-PE and R-PE Labeling Kits. Labeling of antibodies can be both tedious and time-consuming. Without the use of proper techniques and reagents, the conjugation may result in suboptimal or no labeling. AnaSpec’s improved... - November 12, 2008 - AnaSpec, EGT Group
Recombinant Human Soluble RANKL (sRANKL) Launched in USA
OYC International Inc. is pleased to announce the launch of recombinant human soluble RANKL (sRANKL) to support osteoporosis and bone metabolism research initiatives. Receptor activator of NF-kB ligand (RANKL), also designated TRANCE, OPGL and ODF, is a member of the TNF family that is expressed... - November 07, 2008 - OYC International, Inc.
Colorado BioScience Association Honors the Best of Colorado’s Bioscience Industry
The Colorado BioScience Association (CBSA) has released winners of its 2008 Awards Program. Official presentation of the awards occurs Thursday, November 13, 6:30 to 8:30 p.m., at the CBSA’s annual awards dinner. Governor Bill Ritter, Jr., recipient of one of this year’s Chairman’s Awards, will serve as the Cooley Godward Kronish keynote speaker for this event as the Colorado Bioscience Association celebrates its fifth anniversary. - November 07, 2008 - Colorado BioScience Association
AnaSpec Introduces Fluorescent Calcium Indicators
Calcium plays a vital role in the regulation of cardiac contractility, growth and gene expression; consequently, calcium measurement is critical in numerous biological investigations. Fluorescent probes that show spectral responses upon Ca2+ binding have enabled researchers to investigate changes... - November 05, 2008 - AnaSpec, EGT Group
National Speakers – Steven Burrill, Guy Kawasaki & T.R. Reid – and Expo with More Than 50 Bioscience Vendors To Attract 700+ at BioWest 2008, Nov. 13 & 14, in Denver
Outstanding national speakers Steven Burrill, Guy Kawasaki and T.R. Reid lead the conference lineup for BioWest 2008, plus 50+ bioscience vendors will introduce their products and services to more than 700 attendees. The BioWest Conference and Expo is the Rocky Mountain region’s preferred venue for visiting with researchers about their newest discoveries and meeting founders of the area’s most innovative and promising bioscience start-up companies. - November 01, 2008 - Colorado BioScience Association
20+ Colorado Bioscience Companies Are Looking to Fill Positions at the 2008 BioWest Conference & Expo’s First Annual Job Fair
The Colorado BioScience Association (CBSA) is hosting a new Bioscience Job Fair the afternoon of November 14, 1:30 to 4 p.m., following the 2008 BioWest Grand Finale Luncheon. The BioWest Conference and Expo is the Rocky Mountain region’s preferred venue for visiting with researchers about their newest discoveries and meeting founders of the area’s most innovative and promising bioscience start-up companies. - October 30, 2008 - Colorado BioScience Association
AnaSpec Introduces New PKD1 & PKD2 Antibodies
Protein kinase D (PKD belongs to the calcium calmodulin superfamily of kinases (2-3). - October 23, 2008 - AnaSpec, EGT Group
Neowater Solubilization Service
Neowater provides a new solubilization service, which has significant value-added in drug-delivery applications due to increased stability of compounds solvated. - October 20, 2008 - Do-Coop
Newtechbio Offers WHITECAP(TM) SC Aquatic Herbicide with Fluridone
Newtechbio, Inc. announced today that it has expanded its product offering line with the addition of WHITECAP SC herbicide with Fluridone for the control of aquatic weeds in fresh water ponds, lakes, reservoirs, potable water sources, drainage canals and irrigation canals. WHITECAP SC contains Fluridone, a proven ingredient designed to kill and control Duckweed, Milfoil, Watermeal and other weeds. - October 18, 2008 - Newtechbio, Inc.
AnaSpec Introduces New SensoLyteTM MMP ELISA Kits
MMPs are key players in normal and pathological processes, including embryogenesis, wound healing, inflammation, arthritis, and cancer. - October 18, 2008 - AnaSpec, EGT Group
The 2008 BioWest Conference and Expo Announces National Speaker Lineup, New Job Fair and Popular Venture Showcase Competition
General registration is now open for the Rocky Mountain Region’s Premier Bioscience Conference and Expo, BioWest 2008. More than 700 participants are expected at this year’s event, November 13-14, at the Grand Hyatt in Denver. Noted author of The Art of the Start & business innovation expert Guy Kawasaki leads a prominent lineup of national presenters for BioWest 2008. - October 16, 2008 - Colorado BioScience Association
AnaSpec’s FRET Feature Article Available at Photonics.com
AnaSpec published a technical article entitled, “Sensitive FRET Assays Aid Drug Discovery” in the August edition of Biophotonics International. - October 16, 2008 - AnaSpec, EGT Group
BellBrook Labs Announces a Kinase/ATPase Assay That is "2" Sensitive
The Transcreener ADP2 FP Assay is a homogenous fluorescence polarization assay that enables the facile detection and screening of established drug targets including protein and lipid kinases as wells as emerging targets such as heat shock proteins and other ATPases. - October 15, 2008 - BellBrook Labs
Finalists Selected for The BioWest 2008 Venture Showcase Competition
New therapeutic small molecule drugs; devices made of unique materials; a highly-sensitive biosensor; advanced DNA immunotherapies; high-protein, low-cost fish food; and, new materials for use in perio-plastic surgical procedures comprise the six finalists in this year’s BioWest Venture Showcase competition. The finalists were selected from a group of 22and will be presenting at the BioWest Venture Showcase on November 13 at the Grand Hyatt-Denver, 1750 Welton. - October 15, 2008 - Colorado BioScience Association
AnaSpec Introduces Histone GO™ Peptides - Acetylated & Methylated
The core histones (H2A, H2B, H3 and H4) act as spools around which DNA winds. Covalent modification on the amino terminal of the core histones through de/acetylation, de/methylation and de/phosphorylation affect chromatin structure and exquisitely regulate gene expression.1-3 Histone... - October 11, 2008 - AnaSpec, EGT Group
“GH2” Hydrogen Collection Bladders
While the world re-visits Hydrogen as a viable alternative fuel, the issues of safety and economy remain. - October 03, 2008 - Aero Tec Laboratories, Inc.
EOS Remediation Secures Patent Rights for Vadose Zone Remediation by Physical and Biological Means
EOS Remediation, LLC, a developer and manufacturer of advanced technologies for groundwater restoration, and Savannah River Nuclear Solutions, LLC announced that they have signed an Exclusive Patent License Agreement. This royalty-based agreement grants EOS Remediation an exclusive world-wide... - October 02, 2008 - EOS Remediation, LLC
TBTA - Click Chemistry Ligand for Cu (I)
Copper (I) species are powerful catalysts for the formation of 1,2,3-triazoles from azides and alkynes. The general thermodynamic instability of Cu(I) however, results in easy oxidation to Cu(II) and/or disproportionation to Cu(0) and Cu(II).1 TBTA, Tris-[(1-benzyl-1H-1,2,3-triazol-4-yl)... - September 24, 2008 - AnaSpec, EGT Group
Gene Oracle Unleashes GeneIOS
The Complete Solution for Synthetic Genes in a Single Day. - September 23, 2008 - Gene Oracle Inc.
Genomic Nanosystems Announces Exclusive Licensing Agreement to Sequenom for the Right to Use Digital PCR in Prenatal Testing and Mass Spectrometry
Genomic Nanosystems, LLC, today announced that it has granted an exclusive license to Sequenom, Inc. (Nasdaq: SQNM) for the right to use Digital PCR in noninvasive prenatal research and diagnostics on a technology, platform and sample independent basis, and has granted the exclusive right to use... - September 22, 2008 - Genomic Nanosystems
AnaSpec Celebrates 15 Year Anniversary
Since its inception in 1993, AnaSpec has provided drug discovery reagents to some of the world’s largest biotech, pharmaceutical, and academic research institutions. - September 21, 2008 - AnaSpec, EGT Group
Tygon® Tubing Products Now Available from Professional Plastics
Professional Plastics, Inc. is now offering a full range of Tygon ® tubing products for fluid handling applications. Saint Gobain produces more than 40 grades of Tygon®, Tygothane®, Norprene®, Versilic ® and more. These products are sold online from www.professionalplastics.com/TYGONTUBING. - September 19, 2008 - Professional Plastics, Inc.
AnaSpec to Manufacture BD™ Fluorescent Dyes for BD Biosciences
AnaSpec announced today that BD Biosciences, a business segment of BD (Becton Dickinson and Company), has chosen it to manufacture and supply the BD™ H7, Calcein AM and DiIC12(3) Fluorescent Dyes. “BD Biosciences has a tremendous reputation in the industry for innovative products of... - September 19, 2008 - AnaSpec, EGT Group
AnaSpec Introduces High Performance Labeled Streptavidins
AnaSpec has introduced its latest collection of streptavidins labeled with its patented HiLyte Fluor(TM) and HiLytePlus(TM) dyes which promise brighter fluorescence and better photostability compared to FITC and Cyâ dyes. - September 18, 2008 - AnaSpec, EGT Group
RayBiotech and AnaSpec Sign Licensing Agreement for HiLyte™ Dyes
AnaSpec and RayBiotech today announced a licensing agreement that will allow RayBiotech to label antibodies with AnaSpec HiLytePlus™ and HiLyte Fluor™ dyes and integrate into protein and antibody arrays. HiLytePlus™ and HiLyte Fluor™ are AnaSpec's proprietary series of high... - September 17, 2008 - AnaSpec, EGT Group
AnaSpec and Cyclex Sign Licensing Agreement for Deacetylase Activity Assay Kits
AnaSpec and Cyclex Co. Ltd. today announced a licensing agreement that will allow AnaSpec to make, use, and sell deacetylase activity assay kits and the related products as covered by Cyclex’s patent # ‘s EP 1243658, US 7033778, US 7256013. "We are pleased to partner with Cyclex... - September 14, 2008 - AnaSpec, EGT Group
Fundamentals of Chinese Pharma Industry Remain Strong Despite Anticipated Slower Growth in 2H/2008
While the Chinese pharmaceutical industry reported highly positive performance in the first half of 2008, WiCON International Group, the publisher of Pharma China and China Pharmaceutical Guide, expects the industry’s growth to slow down somewhat in the second half of 2008. Most... - September 12, 2008 - WiCON International Group LLC
AnaSpec Introduces Kinase Substrates as GO™ Peptides
Protein kinases are a transferase family of self-regulatory enzymes that catalyze the phosphorylation of other proteins by covalently attaching phosphate groups to them, using ATP as a phosphate donor. Reversible protein phosphorylation-dephosphorylation has a principal role in the regulation of... - September 11, 2008 - AnaSpec, EGT Group
Recombinant MOG Proteins - New
Expanding on its world-class collection of MOG peptides and assay kits, AnaSpec is pleased to announce the release of 3 MOG recombinant proteins, for human, mouse and rat. These proteins, with sequences corresponding to human, mouse and rat extracellular domain, together with a 6x His tag were... - September 10, 2008 - AnaSpec, EGT Group
New Guidance Document Offers Strategy for Remediation of Perchlorate in Groundwater
Solutions-IES, Inc., a leading provider of professional environmental engineering and remediation services for government and commercial clients around the world, in association with the Environmental Security Technology Certification Program (ESTCP), announces the publication and release of a... - September 09, 2008 - Solutions-IES, Inc.
Colorado BioScience Association Seeks Region’s Top Innovators for Venture Showcase Competition at 2008 BioWest Conference & Expo
The organizers of BioWest 2008 are again looking for the best bioscience start-ups in the region as candidates for the $10,000 Dorsey & Whitney Venture Showcase Award. Six companies will be chosen to present at the showcase on Thursday, November 13, 2008, and will be judged by a panel of national venture capitalists. Deadline for entry is Monday, October 1. - September 06, 2008 - Colorado BioScience Association
AnaSpec Peptides Used in Latest Alzheimer’s Research Findings by VU University Medical Centre and Lund University
At the 2008 International Conference for Alzheimer’s Disease, the VU University Medical Centre and Lund University presented a joint poster entitled, “Aβ1-42 binding and uptake by primary human astrocytes in vitro: Effects of a1-Antichymotrypsin.” The authors of the study... - August 31, 2008 - AnaSpec, EGT Group